Who is sponsoring NCT05338138?

NCT05338138 is sponsored by Zagazig University.

What drugs are being tested in NCT05338138?

Interventions in NCT05338138: ultrasound guided central venous catheter insertion.

What condition does NCT05338138 study?

NCT05338138 studies Central Venous Catheter Placement.

Is NCT05338138 still recruiting?

NCT05338138 is currently completed. Last updated 21 April 2022.

Last reviewed 2022-04-21 · How we verify

NCT05338138

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Point of Care Ultrasonography Versus Standard Blind Technique for Central Venous Catheter Insertion in Emergency Hospital

Completed Last updated 21 April 2022

What this trial tests

trial testing ultrasound guided central venous catheter insertion in Central Venous Catheter Placement in 200 participants. Completed in 5 April 2022.

Timeline

20 October 2021

Primary endpoint
30 March 2022

5 April 2022

Quick facts

Lead sponsor	Zagazig University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	20 October 2021
Primary completion	30 March 2022
Estimated completion	5 April 2022
Sites	1 location across Egypt

Drugs / interventions tested

ultrasound guided central venous catheter insertion

Conditions studied

Central Venous Catheter Placement — all drugs for Central Venous Catheter Placement →

Sponsor

Zagazig University

Who can join

18 and older, any sex, with Central Venous Catheter Placement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A lot of complications occur during central venous catheter insertion in intensive care units all over the world most commonly pneumothorax, misplacement and infection. So in this study we will assess the effect of using ultrasonography guidance for CVC insertion to reduce incidence of complications and to confirm placement compared to standard blind technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05338138 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 21 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05338138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing